BCM
ACHN

Bourgeon Capital Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Bourgeon Capital Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20,000
Closed -$72K – 250
2019
Q3 		$72K Buy
+20,000
New +$77.1K 0.04% 98
2019
Q1 		– Sell
-26,500
Closed -$42K – 82
2018
Q4 		$42K Sell
26,500
-16,000
-38% -$45.2K 0.03% 67
2018
Q3 		$156K Buy
42,500
+10,000
+31% +$29.8K 0.08% 73
2018
Q2 		$92K Sell
32,500
-2
-0% -$7 0.05% 72
2018
Q1 		$121K Sell
32,502
-16,002
-33% -$52.4K 0.07% 71
2017
Q4 		$140K Buy
48,504
+19,004
+64% +$69K 0.08% 82
2017
Q3 		$132K Sell
29,500
-5,000
-14% -$22.2K 0.08% 82
2017
Q2 		$158K Hold
34,500
– – 0.1% 73
2017
Q1 		$145K Hold
34,500
– – 0.09% 81
2016
Q4 		$142K Buy
34,500
+13,000
+60% +$69.1K 0.09% 85
2016
Q3 		$174K Sell
21,500
-9,000
-30% -$76.5K 0.11% 84
2016
Q2 		$238K Buy
30,500
+9,000
+42% +$77.2K 0.15% 76
2016
Q1 		$166K Buy
21,500
+10,000
+87% +$73.2K 0.11% 86
2015
Q4 		$124K Sell
11,500
-49,200
-81% -$447K 0.08% 89
2015
Q3 		$419K Sell
60,700
-30,000
-33% -$244K 0.29% 65
2015
Q2 		$804K Buy
90,700
+35,600
+65% +$337K 0.49% 57
2015
Q1 		$543K Buy
55,100
+22,400
+69% +$280K 0.33% 65
2014
Q4 		$401K Buy
32,700
+12,700
+64% +$155K 0.24% 78
2014
Q3 		$200K Buy
+20,000
New +$186K 0.12% 99
2014
Q2 		– Sell
-30,000
Closed -$99K – 122
2014
Q1 		$99K Buy
+30,000
New +$105K 0.06% 92

Other funds holding ACHN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bourgeon Capital Management's ACHN Position: Q4 2019 in Review

Bourgeon Capital Management sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 20,000 shares — an estimated $72K sold.

Bourgeon Capital Management first reported a position in ACHN in Q1 2014 and held it in 20 quarters. The position peaked at $804K in Q2 2015. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

  • Bourgeon Capital Management reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Bourgeon Capital Management sold 20,000 Achillion Pharmaceuticals shares in Q4 2019, an estimated $72K.
  • Bourgeon Capital Management first reported a position in Achillion Pharmaceuticals in Q1 2014 and held it in 20 quarters.
  • Bourgeon Capital Management's Achillion Pharmaceuticals position peaked at $804K in Q2 2015.
  • 132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Bourgeon Capital Management's 13F filing for Q4 2019, filed 4 Feb 2020.